Gefapixant - Cough / Cough suppression

You are here : Home > Formulary Search > Gefapixant - Cough / Cough suppression

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative

Formulations :

Tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

NFD2

SPC

Restrictions / Comments :

Important

Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Gefapixant

Indication :

Cough / Cough suppression

Group Name :

Keywords :

Brand Names Include :

Lyfnua

Important Information :

Refractory or unexplained chronic cough

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Other Indications

Below are listed other indications that Gefapixant is used to treat.

No records returned.

Other Drugs

Below are listed other drugs that are used to treat Cough / Cough suppression.

Committee Recommendations (1)

04 Jun 25 - Not Set

This drug has not yet been assessed for formulary status and is not currently on the APC work-plan.

This drug has not yet been evaluated by the Surrey Heartlands ICS Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined.

Before prescribing this drug, it is recommended that clinicians contact their Medicines Optimisation team to discuss possible alternatives/options.

The APC will consider recommending the prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicians can contact syheartlandsicb.APC@nhs.net if they wish to make a submission.